Adipose-derived mesenchymal stem cell therapy for connective tissue diseases and complications
Authors:
Open Access
- 19 July 2024
- journal article
- review article
- Published by Springer Nature in Inflammation and Regeneration
- Vol. 44 (1) , 1-23
Abstract
Mesenchymal stem cells (MSCs) may be effective in treating connective tissue disease and associated organ damage, leveraging their anti-inflammatory and immunoregulatory effects. Moreover, MSCs may possess the ability to produce antiapoptotic, proliferative, growth, angiogenic, and antifibrotic factors. Among MSCs, adipose-derived MSCs (ASCs) stand out for their relative ease of harvesting and abundance. Additionally, studies have indicated that compared with bone marrow-derived MSCs, ASCs have superior immunomodulatory, proangiogenic, antiapoptotic, and antioxidative properties. However, relatively few reviews have focused on the efficacy of ASC therapy in treating connective tissue disease (CTD) and interstitial lung disease (ILD). Therefore, this review aims to evaluate evidence from preclinical studies that investigate the effectiveness of MSC therapy, specifically ASC therapy, in managing CTD and ILD. Moreover, we explore the outcomes of documented clinical trials. We also introduce an innovative approach involving the utilization of pharmacologically primed ASCs in the CTD model to address the current challenges associated with ASC therapy.Keywords
Funding Information
- Grant-in-Aid for Young Scientists
- Grant-in-Aid for Young Scientists
- Grant-in-Aid for Young Scientists
This publication has 123 references indexed in Scilit:
- Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cellsBlood, 2005
- Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cellsBlood, 2005
- Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase–mediated tryptophan degradationBlood, 2004
- Secretion of Angiogenic and Antiapoptotic Factors by Human Adipose Stromal CellsCirculation, 2004
- Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuliBlood, 2002
- Stem cell technology and bioceramics: From cell to gene engineeringJournal of Biomedical Materials Research, 1999
- Sulfated Oligosaccharides Promote Hepatocyte Growth Factor Association and Govern Its Mitogenic ActivityJournal of Biological Chemistry, 1995
- Heparin as an Inducer of Hepatocyte Growth Factor1The Journal of Biochemistry, 1993
- Non-Anticoagulant Uses of HeparinNew England Journal of Medicine, 1993
- High dose continuous infusion of bleomycin in mice: a new model for drug-induced pulmonary fibrosis.The Journal of Pharmacology and Experimental Therapeutics, 1987